Skip to content

Safety , Efficacy and Tolerability of 35% Glycolic acid peel versus 15% Trichloroacetic acid peel in Melasma

SAFETY, EFFICACY AND TOLERABILITY OF 15% TRICHLOROACETIC ACID AND 35% GLYCOLIC ACID PEELS IN MELASMA -DOUBLE BLINDED RANDOMIZED CONTROL TRIAL

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/05/019205
Enrollment
40
Registered
2019-05-20
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L768- Other intraoperative and postprocedural complications of skin and subcutaneous tissue

Interventions

Intervention1: 35% GLYCOLIC ACID: 35% Glycolic acid peel every 2 weeks for a maximum of 6 weeks Control Intervention1: Jayaseelan: Statistical analyst Control Intervention2: 15 % TRICHLOROACETIC ACID:

Sponsors

AARUPADAI VEEDU MEDICAL COLLEGE AND HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age >20 years 2) Patients with melasma aged between 20 and 55 years reporting to the outpatient department of dermatology 3) Both sexes are included

Exclusion criteria

Exclusion criteria: o Pregnant females, females on oral contraceptive pills. o Patients with recurrent herpes infection. o Patients with hypertrophic scars or keloids. o Patients with active dermatitis. Patients less than 20 and more than 55 years are excluded from the study. o Patients not willing to undergo the study.

Design outcomes

Primary

MeasureTime frame
Safety, Efficacy and Tolerability of 35% Glycolic acid peel versus 15% Trichloroacetic acid peel in Melasma. Timepoint: Safety, Efficacy and Tolerability of 35% Glycolic acid peel versus 15% Trichloroacetic acid peel in Melasma.

Secondary

MeasureTime frame
Safety, Efficacy and Tolerability of 35% Glycolic acid peel versus 15% Trichloroacetic acid peel in Melasma. Timepoint: to compare outcome

Countries

India

Contacts

Public ContactDrPRIYATHARSHINIV

AARUPADAI VEEDU MEDICAL COLLEGE AND HOSPITAL

gopi3333@yahoo.com9047458195

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026